{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:25:41Z","timestamp":1787293541935,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2020-NR049559"],"award-info":[{"award-number":["RS-2020-NR049559"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12541-z","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:00:20Z","timestamp":1787292020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JI-CS004, a chloroform fraction of SH003, induces reactive oxygen species-dependent intrinsic apoptosis via endoplasmic reticulum stress-associated mitochondrial dysfunction in human colorectal cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Tae-Hyoun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-430X","authenticated-orcid":false,"given":"Seong-Gyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"3","key":"12541_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12541_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"12541_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u2013344","journal-title":"Gut"},{"issue":"9","key":"12541_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, Abou-Kheir W (2024) Colorectal cancer: Recent advances in management and treatment. World J Clin Oncol 15(9):1136\u20131156","journal-title":"World J Clin Oncol"},{"issue":"1","key":"12541_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5(1):22","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"12541_CR6","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1002\/cam4.5594","volume":"12","author":"SC Ma","year":"2023","unstructured":"Ma SC, Zhang JQ, Yan TH, Miao MX, Cao YM, Cao YB, Zhang LC, Li L (2023) Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med 12(10):11073\u201311096","journal-title":"Cancer Med"},{"issue":"1","key":"12541_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v3.i1.1","volume":"3","author":"SS Kanwar","year":"2012","unstructured":"Kanwar SS, Poolla A, Majumdar AP (2012) Regulation of colon cancer recurrence and development of therapeutic strategies. World J Gastrointest Pathophysiol 3(1):1\u20139","journal-title":"World J Gastrointest Pathophysiol"},{"key":"12541_CR8","doi-asserted-by":"publisher","first-page":"1571731","DOI":"10.3389\/fimmu.2025.1571731","volume":"16","author":"JM Oh","year":"2025","unstructured":"Oh JM, Kim S, Tsung C, Kent E, Jain A, Ruff SM, Zhang H (2025) Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type. Front Immunol 16:1571731","journal-title":"Front Immunol"},{"key":"12541_CR9","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.adcanc.2024.100114","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Bhowmick M, Pal R, Khatoon H, Kumar P, Sharma H, Garg A, Kumar S, Das U (2024) Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success. Adv Cancer Biology - Metastasis 10:100114","journal-title":"Adv Cancer Biology - Metastasis"},{"issue":"1","key":"12541_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosello S, Arnold D, Normanno N, Taieb J, Seligmann J, De Baere T, Osterlund P, Yoshino T et al (2023) Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34(1):10\u201332","journal-title":"Ann Oncol"},{"issue":"3","key":"12541_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA et al (2023) Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J Clin Oncol 41(3):678\u2013700","journal-title":"J Clin Oncol"},{"issue":"5","key":"12541_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330\u2013338","journal-title":"Nat Rev Cancer"},{"key":"12541_CR13","doi-asserted-by":"publisher","first-page":"995882","DOI":"10.3389\/fmed.2022.995882","volume":"9","author":"L Chen","year":"2022","unstructured":"Chen L, Yang F, Chen S, Tai J (2022) Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review. Front Med (Lausanne) 9:995882","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"12541_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1634\/theoncologist.2017-0203","volume":"23","author":"KK Ciombor","year":"2018","unstructured":"Ciombor KK, Bekaii-Saab T (2018) A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer. Oncologist 23(1):25\u201334","journal-title":"Oncologist"},{"key":"12541_CR15","doi-asserted-by":"publisher","first-page":"1453630","DOI":"10.3389\/fcell.2024.1453630","volume":"12","author":"K Ji","year":"2024","unstructured":"Ji K, Jia H, Liu Z, Yu G, Wen R, Zhang T, Peng Z, Man W, Tian Y, Wang C et al (2024) New insight in immunotherapy and combine therapy in colorectal cancer. Front Cell Dev Biol 12:1453630","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"12541_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-024-03173-x","volume":"43","author":"V Benboubker","year":"2024","unstructured":"Benboubker V, Ramzy GM, Jacobs S, Nowak-Sliwinska P (2024) Challenges in validation of combination treatment strategies for CRC using patient-derived organoids. J Exp Clin Cancer Res 43(1):259","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"12541_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12906-025-05032-4","volume":"25","author":"C Cheon","year":"2025","unstructured":"Cheon C, Ko SG (2025) Efficacy and safety of SH003 on immune function: study protocol for a randomized, double-blind placebo-controlled clinical trial. BMC Complement Med Ther 25(1):293","journal-title":"BMC Complement Med Ther"},{"issue":"22","key":"12541_CR18","doi-asserted-by":"publisher","first-page":"32969","DOI":"10.18632\/oncotarget.8808","volume":"7","author":"HS Choi","year":"2016","unstructured":"Choi HS, Kim MK, Lee K, Lee KM, Choi YK, Shin YC, Cho SG, Ko SG (2016) SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2. Oncotarget 7(22):32969\u201332979","journal-title":"Oncotarget"},{"issue":"8","key":"12541_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-020-02924-w","volume":"11","author":"TW Kim","year":"2020","unstructured":"Kim TW, Cheon C, Ko SG (2020) SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells. Cell Death Dis 11(8):717","journal-title":"Cell Death Dis"},{"key":"12541_CR20","doi-asserted-by":"crossref","unstructured":"Jeong MS, Lee KW, Choi YJ, Kim YG, Hwang HH, Lee SY, Jung SE, Park SA, Lee JH, Joo YJ et al (2021) Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer. Int J Mol Sci 22(16):8405","DOI":"10.3390\/ijms22168405"},{"key":"12541_CR21","doi-asserted-by":"crossref","unstructured":"Choi YJ, Lee K, Yoon JH, Cho SG, Kim YG, Jeong M, Hwang HH, Lee SY, Jung SE, Ko SG (2022) SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer. Biomed Res Int 3647900","DOI":"10.1155\/2022\/3647900"},{"key":"12541_CR22","doi-asserted-by":"publisher","first-page":"4120334","DOI":"10.1155\/2021\/4120334","volume":"2021","author":"K Lee","year":"2021","unstructured":"Lee K, Ku JM, Choi YJ, Hwang HH, Jeong M, Kim YG, Kim MJ, Ko SG (2021) Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL\/6 Mice. Evid Based Complement Alternat Med 2021:4120334","journal-title":"Evid Based Complement Alternat Med"},{"key":"12541_CR23","doi-asserted-by":"publisher","first-page":"153473542091144","DOI":"10.1177\/1534735420911442","volume":"19","author":"C Cheon","year":"2020","unstructured":"Cheon C, Ko SG (2020) A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer. Integr Cancer Ther 19:1534735420911442","journal-title":"Integr Cancer Ther"},{"key":"12541_CR24","doi-asserted-by":"publisher","first-page":"153473542412934","DOI":"10.1177\/15347354241293451","volume":"23","author":"C Cheon","year":"2024","unstructured":"Cheon C, Lee HW, Sym SJ, Ko SG (2024) Safety of the Herbal Medicine SH003 in Patients With Solid Cancer: A Multi-Center, Single-Arm, Open-Label, Dose-Escalation Phase I Study. Integr Cancer Ther 23:15347354241293451","journal-title":"Integr Cancer Ther"},{"key":"12541_CR25","doi-asserted-by":"publisher","first-page":"153473542513638","DOI":"10.1177\/15347354251363892","volume":"24","author":"C Cheon","year":"2025","unstructured":"Cheon C, Kim H, Kang SY, Lee SY, Park KH, Ko SG (2025) Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial. Integr Cancer Ther 24:15347354251363892","journal-title":"Integr Cancer Ther"},{"issue":"10","key":"12541_CR26","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453\u2013462","journal-title":"Curr Biol"},{"key":"12541_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies H, Berndt C, Jones DP (2017) Oxidative Stress. Annu Rev Biochem 86:715\u2013748","journal-title":"Annu Rev Biochem"},{"key":"12541_CR28","doi-asserted-by":"publisher","first-page":"725710","DOI":"10.1155\/2013\/725710","volume":"2013","author":"M Perse","year":"2013","unstructured":"Perse M (2013) Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Int 2013:725710","journal-title":"Biomed Res Int"},{"issue":"7","key":"12541_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579\u2013591","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"12541_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/ars.2014.5851","volume":"21","author":"SS Cao","year":"2014","unstructured":"Cao SS, Kaufman RJ (2014) Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 21(3):396\u2013413","journal-title":"Antioxid Redox Signal"},{"issue":"6059","key":"12541_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334(6059):1081\u20131086","journal-title":"Science"},{"issue":"8","key":"12541_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21(8):421\u2013438","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"12541_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","volume":"6","author":"HP Harding","year":"2000","unstructured":"Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6(5):1099\u20131108","journal-title":"Mol Cell"},{"issue":"24","key":"12541_CR34","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1101\/gad.1250704","volume":"18","author":"SJ Marciniak","year":"2004","unstructured":"Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18(24):3066\u20133077","journal-title":"Genes Dev"},{"issue":"7","key":"12541_CR35","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107(7):881\u2013891","journal-title":"Cell"},{"issue":"5453","key":"12541_CR36","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.287.5453.664","volume":"287","author":"F Urano","year":"2000","unstructured":"Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453):664\u2013666","journal-title":"Science"},{"issue":"15","key":"12541_CR37","doi-asserted-by":"publisher","first-page":"13045","DOI":"10.1074\/jbc.M110636200","volume":"277","author":"X Chen","year":"2002","unstructured":"Chen X, Shen J, Prywes R (2002) The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J Biol Chem 277(15):13045\u201313052","journal-title":"J Biol Chem"},{"issue":"6","key":"12541_CR38","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S1097-2765(00)00133-7","volume":"6","author":"J Ye","year":"2000","unstructured":"Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS, Goldstein JL (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6(6):1355\u20131364","journal-title":"Mol Cell"},{"key":"12541_CR39","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/ncomms3550","volume":"4","author":"M Tantama","year":"2013","unstructured":"Tantama M, Martinez-Francois JR, Mongeon R, Yellen G (2013) Imaging energy status in live cells with a fluorescent biosensor of the intracellular ATP-to-ADP ratio. Nat Commun 4:2550","journal-title":"Nat Commun"},{"key":"12541_CR40","doi-asserted-by":"crossref","unstructured":"Green DR (2022) The Mitochondrial Pathway of Apoptosis: Part I: MOMP and Beyond. Cold Spring Harb Perspect Biol 14(5):a041038","DOI":"10.1101\/cshperspect.a041038"},{"issue":"8","key":"12541_CR41","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/sj.cdd.4401963","volume":"13","author":"JE Chipuk","year":"2006","unstructured":"Chipuk JE, Bouchier-Hayes L, Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13(8):1396\u20131402","journal-title":"Cell Death Differ"},{"issue":"39","key":"12541_CR42","doi-asserted-by":"publisher","first-page":"41706","DOI":"10.18632\/oncotarget.5991","volume":"6","author":"C Denise","year":"2015","unstructured":"Denise C, Paoli P, Calvani M, Taddei ML, Giannoni E, Kopetz S, Kazmi SM, Pia MM, Pettazzoni P, Sacco E et al (2015) 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Oncotarget 6(39):41706\u201341721","journal-title":"Oncotarget"},{"key":"12541_CR43","doi-asserted-by":"crossref","unstructured":"Zhao Z, Mei Y, Wang Z, He W (2022) The Effect of Oxidative Phosphorylation on Cancer Drug Resistance. Cancers (Basel) 15(1):62","DOI":"10.3390\/cancers15010062"},{"issue":"2","key":"12541_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jfda.2016.08.006","volume":"25","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Ra JH, Jee Y, Kim JS (2017) Impact of different partitioned solvents on chemical composition and bioavailability of Sasa quelpaertensis Nakai leaf extract. J Food Drug Anal 25(2):316\u2013326","journal-title":"J Food Drug Anal"},{"issue":"5","key":"12541_CR45","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315\u20132319","journal-title":"Nat Protoc"},{"issue":"2","key":"12541_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/cdr.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner WH, Okechukwu CC (2023) Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist 6(2):257\u2013272","journal-title":"Cancer Drug Resist"},{"issue":"5","key":"12541_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.21873\/anticanres.17574","volume":"45","author":"HH Hwang","year":"2025","unstructured":"Hwang HH, Yoo JS, Je JH, Lee HC, Kim TH, Sim YB, Cho KJ, Kim T, Cho SG, Ko SG (2025) SH003 Inhibits Proliferation and Induces Apoptosis in NSCLC Cell Lines by Inhibiting the Receptor Tyrosine Kinase-related Pathway. Anticancer Res 45(5):1981\u20131995","journal-title":"Anticancer Res"},{"issue":"5","key":"12541_CR48","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.21873\/anticanres.17573","volume":"45","author":"HH Hwang","year":"2025","unstructured":"Hwang HH, Yoo JS, Je JH, Lee HC, Kim TH, Sim YB, Cho KJ, Cho SG, Cheon C, Ko SG (2025) SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway. Anticancer Res 45(5):1965\u20131980","journal-title":"Anticancer Res"},{"issue":"5","key":"12541_CR49","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.32604\/or.2025.059791","volume":"33","author":"HS Choi","year":"2025","unstructured":"Choi HS, Ku JK, Ko SG, Yun PY (2025) Anticancer effects of SH003 and its active component Cucurbitacin D on oral cancer cell lines via modulation of EMT and cell viability. Oncol Res 33(5):1217\u20131227","journal-title":"Oncol Res"},{"issue":"7","key":"12541_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00262-025-04064-6","volume":"74","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Lee SE, Kim D, Lim HI, Choi DK, Park BK, Jeon CY, Ko SG (2025) The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer. Cancer Immunol Immunother 74(7):198","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"12541_CR51","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.21873\/anticanres.16992","volume":"44","author":"YJ Choi","year":"2024","unstructured":"Choi YJ, Chung YH, Lee K, Jeong M, Ko SG (2024) SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway. Anticancer Res 44(5):1905\u20131913","journal-title":"Anticancer Res"},{"issue":"2","key":"12541_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR (2018) The Unfolded Protein Response and Cell Fate Control. Mol Cell 69(2):169\u2013181","journal-title":"Mol Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12541-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:00:22Z","timestamp":1787292022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12541-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12541"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12541-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report there are no competing interests to declare.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Kyung Hee University Institutional Animal Care and Use Committee (KHSASP-25-080) and conducted according to the ARRIVE guidelines. This study did not involve human participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, AI-assisted tools (ChatGPT) were used solely to improve the readability and clarity of the English text. All content generated with the help of AI tools was thoroughly reviewed, revised, and verified by the authors, who take full responsibility for the final version of the manuscript. No AI tools were used for data analysis, interpretation of results or the generation of scientific conclusions.","order":3,"name":"Ethics","label":"Use of artificial intelligence tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1435"}}